The failings were laid bare in the Royal College of Physicians (RCP) review of treatment provided by retired clinical oncologist Ian Brown who worked at the trust from 1996 to 2024.
Fiona Tinsley, partner and head of clinical negligence & serious injury at Brabners, which is representing over 40 patients of the trust, said: ‘We are calling on the health secretary to establish a full, independent public inquiry, with patients and their families at its heart. It needs to establish how these failures were allowed to become embedded, why the safeguards designed to protect patients did not work, who had opportunities to intervene and how many more people may have been affected.'
The report documents how patients' chemotherapy treatment was prolonged beyond accepted national guidance with some experiencing life changing harm.
Becky Jones was 21 when she was told she had a grade 4 glioblastoma and six to 12 months to live. She received more than 100 cycles of temozolomide over more than a decade before independent experts instructed by Brabners concluded that she had never had a brain tumour and that her imaging was consistent with tumefactive demyelination.
David Bown, who was diagnosed with a brain tumour in 2016, suffered permanent neurological damage following complications after surgery and was later treated with temozolomide chemotherapy for more than eight years. His condition has since deteriorated further and he has now lost the ability to speak.
UHCW chief executive, Professor Andy Hardy and chair, Sue Noyes, said: ‘We are deeply sorry to all the patients and families affected by failures within our neuro-oncology service under the care of retired clinical oncologist Ian Brown. We recognise the concern, distress and loss of trust experienced by those who placed their faith in us during some of the most difficult moments of their lives.'
The trust said it was extending its historical care review back to 2005 and had taken decisive steps to strengthen clinical governance and ensure all treatment decisions were made collaboratively within robust multidisciplinary teams with enhanced continued scrutiny.
UHCW added it was undertaking an independent review of speaking up processes to ensure staff feel fully supported and confident in raising any concerns.
